Sign in

You're signed outSign in or to get full access.

John M. Mount, Jr.

Director at CHEMEDCHEMED
Board

About John M. Mount, Jr.

Independent director of Chemed Corporation since 2022; age 56. Currently Chief Commercial Officer at Q Mixers (since March 2023), following 20+ years in marketing and sales leadership at The Coca-Cola Company (VP roles in Sports Marketing, Customer Marketing, Commercial & Sales; led The Kroger total beverage team) and earlier general management and sales roles at RJR Nabisco. Holds an MBA from the University of Notre Dame and a B.A. from Denison University .

Past Roles

OrganizationRoleTenureNotes/Impact
Q MixersChief Commercial OfficerBegan March 2023Leads national accounts and field sales customer teams
The Coca-Cola CompanyVice President roles: Sports Marketing; Customer Marketing; Commercial & SalesOver two decadesLed Kroger total beverage team; deep marketing/sales background
RJR NabiscoGeneral management and sales rolesSeveral yearsEarly career operating and sales experience

External Roles

OrganizationRoleTenureCommittees/Impact
Not disclosedThe 2025 proxy biography for Mr. Mount does not list other public company directorships .

Board Governance

  • Independence: Board affirmatively determined Mr. Mount is independent under NYSE standards .
  • Board/Meeting attendance: In 2024, the Board met 5 times; all directors attended at least 80% of Board and applicable Committee meetings. Mr. Mount attended the 2024 Annual Meeting (exceptions were Messrs. Hutton and Heaney) .
  • Board leadership: Roles of CEO and Chair are separated; Chair (Mr. Walsh) is independent. Executive sessions are held at Board meetings .
CommitteeMembershipChair?Financial Expert Designation2024 Committee Meetings
AuditMemberNoYes (SEC-defined “Audit Committee Financial Expert”) 7
CompensationNot a memberNoN/A3
NominatingNot a memberNoN/A1
  • Audit Committee credentials: Audit Committee report lists members including John M. Mount, Jr.; chaired by Patrick P. Grace; all members independent .

Fixed Compensation

Component2024 Amount (USD)
Fees Earned or Paid in Cash$115,500
Stock Awards$166,273
All Other Compensation
Total$281,773
  • Fee schedule (non-employee directors): $80,000 annual fee; $3,000 per Board meeting; committee membership annual fees—Audit $15,000 (member), Compensation $12,000, Nominating $10,000; committee chairs—Audit $30,000, Compensation $20,000, Nominating $15,000; committee meeting fees $1,000 ($500 if same day as Board). Fully vested annual stock awards granted to non-employee directors; in May 2024, directors received fully vested awards of 284 shares (approx. $160,273) .
  • Deferred Compensation: $6,000 credited annually to the Director Deferred Compensation Plan to purchase Capital Stock; Mr. Mount participated in 2024 .

Performance Compensation

Performance MetricApplies to Director Compensation?Notes
TSRNoNon-employee director grants are fully vested stock awards; no performance-conditioned equity disclosed
Revenue growthNoNo performance metrics tied to director compensation disclosed
EBITDA/Operating metricsNoNo PSUs/options for directors disclosed; awards are time-vested at grant (fully vested)

Other Directorships & Interlocks

CompanyRoleCommittee RolesInterlocks/Conflict Notes
Not disclosedThe proxy does not disclose current public company boards for Mr. Mount; no interlocks noted with CHE customers/suppliers .

Expertise & Qualifications

  • Deep marketing/sales leadership experience from The Coca-Cola Company; CCO role at Q Mixers .
  • MBA (University of Notre Dame); B.A. (Denison University) .
  • Audit Committee Financial Expert designation under SEC regulations .
  • Independent director per Board determination .

Equity Ownership

Ownership CategoryShares
Direct and Thrift Plan653
Options Exercisable (within 60 days)
Trusteeships/Family Holdings
Total Beneficial Ownership653
Ownership % of ClassNot shown (<1.0%)
  • Stock ownership guidelines: Non-employee directors must retain 5× annual board retainer—$400,000 in 2024. The Compensation Committee administers these guidelines; as of 12/31/2024, all directors and named executives have met the guidelines or are pursuing plans to meet them within the allotted timeframe .
  • Section 16 compliance: All insiders filed timely in 2024 except Ms. Lindell (10-day late sale); no delinquencies noted for Mr. Mount .

Governance Assessment

  • Committee assignments and effectiveness: Mr. Mount serves on the Audit Committee and is designated a financial expert, supporting Board oversight of financial reporting, compliance, and risk with at least annual ERM reviews; Audit Committee members are independent .
  • Independence and engagement: Independent status, ≥80% attendance threshold met, and presence at 2024 annual meeting indicate solid engagement. Board holds executive sessions and maintains separated Chair/CEO roles to enhance independence .
  • Compensation mix and alignment: 2024 compensation balanced between cash ($115,500) and equity ($166,273) via fully vested stock awards; participation in the Director Deferred Compensation Plan adds ongoing stock accumulation and alignment .
  • Ownership alignment: Beneficial ownership disclosed at 653 shares; directors must maintain holdings equal to $400,000; company states directors are meeting or working toward compliance per policy .
  • Conflicts/related-party exposure: Proxy discloses related-party employment for the CEO’s son; no related-party transactions disclosed concerning Mr. Mount. Company maintains formal related-person transaction review policy overseen by the Audit Committee .

RED FLAGS: None disclosed specific to Mr. Mount (no Section 16 delinquencies; no related-party transactions; independent status maintained) .